# Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

> **NCT04436822** · NA · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 317 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Continuous Glucose Monitoring

## Key facts

- **NCT ID:** NCT04436822
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-15
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-12
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04436822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04436822, "Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04436822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*